Efficacy and safety of the cathepsin K inhibitor, ONO-5334, and alendronate on post-menopausal osteopenia or osteoporosis: 2-year results from the ocean study
暂无分享,去创建一个
T. Spector | S. Boonen | R. Eastell | M. Small | Shinichi Nagase | T. Kuwayama | S. Deacon | J. Sawyer | S. Nagase